REGN5713
R5713-5714-5715-ALG-21111
Phase 3 small_molecule completed
Quick answer
REGN5713 for Allergic Rhinitis is a Phase 3 program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Allergic Rhinitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed